Saturday, 12 September 2026
Saturday, 12 September 2026
- In brief
- 1Your enamel has no living cells, so it cannot heal a hole - but before the hole it can be rebuilt from the outside
- 2Fluoride makes a tougher mineral, not new tissue
- 3Hydroxyapatite pastes matched fluoride in a dish
- 4Two minerals together beat either alone
- 5A peptide that gets under the surface
- 6A fluoride-free toothpaste tied with fluoride
- 7An intensive varnish protocol on baby teeth
- 8Nanosilver rinse and white spots in braces
- 9Acid drinks strip enamel with no bacteria involved
- 10Stomach acid and kefir, tested on real molars
- 11Silver fluoride arrested nearly nine in ten molars
- 12Silver and sodium fluoride compared again
- 13Varnish four times a year, and the number that follows
- 14The health agency put varnish on its essential list
- 15What varnish costs per cavity prevented
- 16How common decay is by seventeen
- 17The bacterium that turns sugar into acid
- 18A sweetener that starved the film
- 19Stevioside cut the sticky matrix
- 20A sugar from breast milk blocked the film
- 21Mouth bacteria found further down
- 22What the mouth's 700 species live on
- 23Cleaning under the gum moved blood pressure
- 24Gum disease and heart attacks, in 146,001 people
- 25Heart failure risk 58% higher
- 26Atrial fibrillation, and what recovery did to it
- 27The heart body that says there is no link
- 28A gum bacterium and the brain's barrier
- 29Diabetes and gums pull each other
- 30Ten years after antibiotics for appendicitis
- 31What the first year looked like
- 32Three treatments ranked at once
- 33A stone in the appendix changes the odds
- 34Sent home on tablets
- 35The first new sunscreen filter in the United States in 25 years
- 36Sixteen of twenty sunscreens missed their number
- 37The trial that showed sunscreen cutting a cancer
- 38What melanin does, and what nobody has tested
- 39Sunscreen changed what the skin's genes did
- 40Iron oxides block the light the filters miss
- 41Most of the added extras are untested
- 42Ultraviolet light rises with altitude
- 43Antibodies against blood you have never met
- 44When the lab's two answers disagreed
- 45Learning to reject after nine bags of blood
- 46Matching five Rh markers instead of one
- 47A third of the dummy group got better
- 48Placebo response fell as country income rose
- 49Active dummies barely changed the answer
- 50The sham group's gain did not vanish when they were told
- 51Melatonin did not prevent delirium
- 52A stroke drug beat placebo by five points
- 53Two more trials, two different answers
- 54Doctors using a dummy that announces itself
12 Sept · Mind & body · In brief
Mind & body · Saturday, 12 September 2026
Mind & body, in brief
54 stories · 66 sources
Swipe up for the day in brief ↑Scroll down for the day in brief ↓
What is moving · 1 of 4
Treating without cutting
A protein coating grew new crystals on eroded human teeth and took their hardness from 1.1 back to 3.1 gigapascals.
What is moving · 2 of 4
Gum trouble reaching the heart
Treating gum disease lowered the upper blood pressure number by about 4.6 points across randomised trials.
What is moving · 3 of 4
Protection that wears off
The World Health Organization found two applications of fluoride varnish a year beat one, and silver fluoride is usually painted on twice a year too.
What is moving · 4 of 4
Labels ahead of the tests
Sixteen of 20 Australian sunscreens sold as SPF 50 or above came in below their label.
Part of the day's signal
One pressure seen across the day runs through Mind & body too.
54 stories
11 sources
Mind & body, in brief
- 1Biomimetic supramolecular protein matrix restores structure and properties of human dental enamel
- 7Effectiveness of Fluoride Varnish in Preventing Dental Caries: Systematic Review and Meta-Analysis
- 9From SPF to skin color, sunscreen's effectiveness is complicated
- 10Effectiveness of silver diamine fluoride and fluoride varnish in arresting caries lesions in permanent molars: A randomized controlled trial
- 11Non-operative Management of Uncomplicated Appendicitis: A Review of Indications, Safety, and Clinical Algorithms
- 12Cardiovascular and anti-inflammatory effects of periodontal therapy: A systematic review and meta-analysis of randomized trials
- 13Association between periodontitis and acute myocardial infarction: a systematic review and meta-analysis
- 14Vascular Endothelial Function in Periodontal Disease: Role of Inflammation
- 15Recommendations and best practice statements on the use of mercury-free dental products to prevent and manage dental caries
- 16PINGing Sunshine: A Review of the Evidence for Adding Non-Filtering Photoprotective Ingredients to Sunscreens
- 17Effectiveness of Bioactive Glass-Based Toothpaste for Early Childhood Caries Prevention: A Randomized Controlled Trial
Your enamel has no living cells, so it cannot heal a hole - but before the hole it can be rebuilt from the outside
Swipe up for the story ↑Scroll down for the story ↓
Tooth enamel is the hardest and most mineralised tissue in the body, and it cannot regenerate, because there is nothing living inside it to do the rebuilding.
pooled from 13 randomised trials and 4,784 participants, with unwanted effects under 5%
253 of the 257 Finnish patients first randomised were still being followed a decade on
the consumer group CHOICE ran the test in 2025 and got readings in the forties, thirties and twenties
Who is involved
Alvaro Mata
a biomedical engineering professor at the University of Nottingham in Britain; he led the team that made the enamel-growing coating
Who is involved
Paul Hatton
a biomaterials professor at the University of Sheffield's dental school in Britain and a member of the British Dental Association's science committee; he called the result an exciting breakthrough
Why it matters
No one has yet tested the coating on a tooth inside a living mouth.
Why it matters
Every result so far comes from extracted human teeth in a laboratory, and the team says it hopes for a first product within about a year.
Why it works on people
A hardness reading taken on an extracted tooth before and after treatment is a real measurement, and it reads like a cure, because nothing in that picture shows the mouth the tooth would have had to survive.
Who gains
The Nottingham team and whoever licenses the coating
A laboratory result in Nature Communications is the step that lets a product be developed, and the group says one is about a year off.
Who pays
Anyone whose decay is found after the surface has collapsed
Remineralisation only reaches a lesion while the enamel over it is still whole; after that a filling is the only option.
Nobody knows yet
Whether the enamel coating does anything in a living mouth.
Every test published so far was on extracted human teeth in a laboratory, and no trial in patients exists. The team says it hopes for a product the following year.
Good news
An engineered protein coating grew new crystals on acid-damaged human enamel and took its hardness from 1.1 back to 3.1 gigapascals, against 3.4 for a tooth that had never been touched.
The short version
That's the story in short.
The whole story has 13 more parts.
or swipe up for the next storyor scroll on for the next story ↓
The whole story, in 13 parts ↓
Part 1 of 13 · Who else is involved
Streptococcus mutans
the mouth bacterium that turns dietary sugar into acid; it is the organism most often blamed for tooth decay
Part 1 of 13 · Who else is involved
The World Health Organization
the United Nations' health agency; it lists fluoride varnish among the medicines every country should keep in stock
Part 2 of 13 · How it unfolded
Every day
acid pulls mineral out, saliva puts mineral back
Early decay
mineral is lost under a surface that is still whole, and can still be replaced
Part 2 of 13 · How it unfolded
After it collapses
the hole is permanent, and only a filling closes it
Next
the Nottingham team says it hopes for a first product the following year
Part 3 of 13
It is made of packed crystals of a mineral called hydroxyapatite, stacked into rods about four to eight thousandths of a millimetre thick.
Part 4 of 13
Those crystals dissolve when the liquid around the tooth turns acid and re-form when it does not, so enamel is losing and gaining mineral all day.
Part 5 of 13
Decay is what happens when the losing runs ahead of the gaining for long enough.
Part 6 of 13
Saliva is the supply line: it dilutes and buffers the acid and carries calcium and phosphate back to the surface.
Part 7 of 13
Fluoride adds no cells.
Part 7 of 13
It joins the crystal and makes a tougher mineral, fluorapatite, which needs a stronger acid to dissolve than ordinary enamel does.
Part 8 of 13
A team led by the University of Nottingham in Britain coated eroded human teeth with an engineered protein that works as a scaffold, and new crystals grew on it in the pattern enamel normally has.
Part 9 of 13
Acid etching had cut those teeth from 3.4 to 1.1 gigapascals of hardness; after the coating they measured 3.1.
Part 10 of 13
The work was published in the journal Nature Communications, and the teeth were extracted samples in a laboratory, not teeth in anybody's mouth.
Part 11 of 13
Alvaro Mata, the biomedical engineering professor who led it, said the team hoped to have a first product out the following year.
Part 12 of 13
About 3.7 billion people have some form of oral disease, and the World Health Organization counts enamel breakdown as a large part of that.
Part 13 of 13
None of this reaches a tooth that has already collapsed into a hole, where a filling is still the only way to close the gap.
10 sources
Your enamel has no living cells, so it cannot heal a hole - but before the hole it can be rebuilt from the outside
- 1Biomimetic supramolecular protein matrix restores structure and properties of human dental enamel
- 2Fluoride: Uses, Benefits and Side Effects
- 3Emerging trends in enamel remineralization
- 4Dental Erosion Management: From Remineralization to Emerging Regenerative Approaches
- 5Oral hygiene agents at work: effects on Streptococcus mutans and caries risk
- 6Nottingham scientists very excited by gel to repair tooth enamel
- 7Effectiveness of Fluoride Varnish in Preventing Dental Caries: Systematic Review and Meta-Analysis
- 8Antibiotic Therapy for Uncomplicated Acute Appendicitis: Ten-Year Follow-Up of the APPAC Randomized Clinical Trial
- 9From SPF to skin color, sunscreen's effectiveness is complicated
- 18Comparison of the Caries Remineralizing Effects of Dentifrices Based on Natural Hydroxyapatite, Synthetic Hydroxyapatite, and Fluoride
The full story
Your enamel has no living cells, so it cannot heal a hole - but before the hole it can be rebuilt from the outside
Tooth enamel is the hardest and most mineralised tissue in the body, and it cannot regenerate, because there is nothing living inside it to do the rebuilding.
It is made of packed crystals of a mineral called hydroxyapatite, stacked into rods about four to eight thousandths of a millimetre thick.
Those crystals dissolve when the liquid around the tooth turns acid and re-form when it does not, so enamel is losing and gaining mineral all day.
Decay is what happens when the losing runs ahead of the gaining for long enough.
Saliva is the supply line: it dilutes and buffers the acid and carries calcium and phosphate back to the surface.
Fluoride adds no cells. It joins the crystal and makes a tougher mineral, fluorapatite, which needs a stronger acid to dissolve than ordinary enamel does.
A team led by the University of Nottingham in Britain coated eroded human teeth with an engineered protein that works as a scaffold, and new crystals grew on it in the pattern enamel normally has.
Acid etching had cut those teeth from 3.4 to 1.1 gigapascals of hardness; after the coating they measured 3.1.
The work was published in the journal Nature Communications, and the teeth were extracted samples in a laboratory, not teeth in anybody's mouth.
Alvaro Mata, the biomedical engineering professor who led it, said the team hoped to have a first product out the following year.
About 3.7 billion people have some form of oral disease, and the World Health Organization counts enamel breakdown as a large part of that.
None of this reaches a tooth that has already collapsed into a hole, where a filling is still the only way to close the gap.
Why it matters. No one has yet tested the coating on a tooth inside a living mouth. Every result so far comes from extracted human teeth in a laboratory, and the team says it hopes for a first product within about a year.
Fluoride makes a tougher mineral, not new tissue
Swipe up for the story ↑Scroll down for the story ↓
Ordinary enamel is hydroxyapatite, which starts dissolving when the liquid around it falls to about pH 5.5.
When fluoride is present, some of it swaps into the crystal and makes fluorapatite, which holds out until about pH 4.5.
Fluoride also slows the bacteria down: inside them it blocks enolase, an enzyme they need to make energy and acid.
So fluoride works from outside the tooth, on the mineral and on the microbes, never on any living part of the tooth.
Why it matters
It explains why fluoride is painted on rather than taken as a course, and why stopping it moves the balance straight back.
2 sources
Fluoride makes a tougher mineral, not new tissue
The full story
Fluoride makes a tougher mineral, not new tissue
Ordinary enamel is hydroxyapatite, which starts dissolving when the liquid around it falls to about pH 5.5. When fluoride is present, some of it swaps into the crystal and makes fluorapatite, which holds out until about pH 4.5.
Why it matters. It explains why fluoride is painted on rather than taken as a course, and why stopping it moves the balance straight back.
Hydroxyapatite pastes matched fluoride in a dish
Swipe up for the story ↑Scroll down for the story ↓
Researchers made early decay on 105 blocks of cattle enamel by feeding a bacterial model 10% sucrose three times a day for four days.
They then brushed the blocks with pastes containing natural hydroxyapatite, synthetic hydroxyapatite or fluoride.
Mineral recovery was 29.2% for the natural hydroxyapatite paste and 27.1% for fluoride, against 9.6% for artificial saliva alone.
Why it matters
Fluoride-free pastes are sold on exactly this comparison, and the comparison has so far been made outside the mouth.
Who gains
Makers of fluoride-free toothpaste
Laboratory papers now report hydroxyapatite pastes matching fluoride on mineral recovery, which is the claim the packaging rests on.
Nobody knows yet
Whether hydroxyapatite pastes prevent cavities in people.
The comparisons with fluoride were run on cattle enamel blocks in acid-and-recovery rigs, which is not a mouth.
3 sources
Hydroxyapatite pastes matched fluoride in a dish
- 17Effectiveness of Bioactive Glass-Based Toothpaste for Early Childhood Caries Prevention: A Randomized Controlled Trial
- 18Comparison of the Caries Remineralizing Effects of Dentifrices Based on Natural Hydroxyapatite, Synthetic Hydroxyapatite, and Fluoride
- 19Remineralization of early caries lesions by calcium hypophosphite in vitro: a surface microhardness study
The full story
Hydroxyapatite pastes matched fluoride in a dish
Researchers made early decay on 105 blocks of cattle enamel by feeding a bacterial model 10% sucrose three times a day for four days. They then brushed the blocks with pastes containing natural hydroxyapatite, synthetic hydroxyapatite or fluoride. Mineral recovery was 29.2% for the natural hydroxyapatite paste and 27.1% for fluoride, against 9.6% for artificial saliva alone.
Why it matters. Fluoride-free pastes are sold on exactly this comparison, and the comparison has so far been made outside the mouth.
Two minerals together beat either alone
Swipe up for the story ↑Scroll down for the story ↓
A second laboratory study put cattle enamel through 14 days of acid and recovery cycles with four toothpastes.
A paste holding both calcium hypophosphite and hydroxyapatite restored 89.7% of the lost hardness. Calcium hypophosphite alone managed 75.4%, hydroxyapatite alone 62.4% and standard 1,450 ppm fluoride 60.3%.
Each group improved from its own starting point; the differences are between the groups.
Why it matters
It points at combinations rather than single ingredients, and at the same time shows how far these results still are from a child's mouth.
1 source
Two minerals together beat either alone
The full story
Two minerals together beat either alone
A second laboratory study put cattle enamel through 14 days of acid and recovery cycles with four toothpastes. A paste holding both calcium hypophosphite and hydroxyapatite restored 89.7% of the lost hardness. Calcium hypophosphite alone managed 75.4%, hydroxyapatite alone 62.4% and standard 1,450 ppm fluoride 60.3%.
Why it matters. It points at combinations rather than single ingredients, and at the same time shows how far these results still are from a child's mouth.
A peptide that gets under the surface
Swipe up for the story ↑Scroll down for the story ↓
A white spot on a tooth is decay that has taken mineral from beneath a surface that is still unbroken.
A self-assembling peptide called P11-4 is designed to soak into that space and give new crystal somewhere to form.
A review of seven controlled clinical studies found P11-4 did better than fluoride on subsurface repair in every one, with laser readings of lesion depth falling by 23% to 41%.
The studies were small and mostly in people wearing braces.
Why it matters
This is one of the few places where the new materials have been compared in actual patients rather than in extracted teeth.
What's really going on
Dentistry is moving from drilling tooth away to putting mineral back, and almost all the evidence for the new pastes, peptides and gels comes from extracted teeth in laboratory rigs rather than from people.
4 sources
A peptide that gets under the surface
- 1Biomimetic supramolecular protein matrix restores structure and properties of human dental enamel
- 18Comparison of the Caries Remineralizing Effects of Dentifrices Based on Natural Hydroxyapatite, Synthetic Hydroxyapatite, and Fluoride
- 19Remineralization of early caries lesions by calcium hypophosphite in vitro: a surface microhardness study
- 20Remineralization Potential of Self-Assembling Peptides Versus Fluoride Agents in White Spot Lesions: A Systematic Review
The full story
A peptide that gets under the surface
A white spot on a tooth is decay that has taken mineral from beneath a surface that is still unbroken. A self-assembling peptide called P11-4 is designed to soak into that space and give new crystal somewhere to form. A review of seven controlled clinical studies found P11-4 did better than fluoride on subsurface repair in every one, with laser readings of lesion depth falling by 23% to 41%.
Why it matters. This is one of the few places where the new materials have been compared in actual patients rather than in extracted teeth.
A fluoride-free toothpaste tied with fluoride
Swipe up for the story ↑Scroll down for the story ↓
A double-blind trial enrolled 1,063 children aged three and four from 12 kindergartens in Hubei province, China.
Half were given a fluoride-free toothpaste containing 7.5% bioactive glass; half got a normal paste with 800 parts per million of fluoride.
After 27 months there was no significant difference in how much new decay appeared, and the same was true at 12 months.
Why it matters
A tie can mean both worked or neither did, and without an untreated arm the trial cannot tell those apart.
Nobody knows yet
Whether the fluoride-free toothpaste result means both worked or neither did.
The trial in 1,063 children compared bioactive glass with fluoride and had no untreated group, so a tie cannot be read either way.
1 source
A fluoride-free toothpaste tied with fluoride
The full story
A fluoride-free toothpaste tied with fluoride
A double-blind trial enrolled 1,063 children aged three and four from 12 kindergartens in Hubei province, China. Half were given a fluoride-free toothpaste containing 7.5% bioactive glass; half got a normal paste with 800 parts per million of fluoride. After 27 months there was no significant difference in how much new decay appeared, and the same was true at 12 months.
Why it matters. A tie can mean both worked or neither did, and without an untreated arm the trial cannot tell those apart.
An intensive varnish protocol on baby teeth
Swipe up for the story ↑Scroll down for the story ↓
A clinical study followed white spots on children's primary teeth for a year, checking them by eye and with a laser fluorescence meter at three, six, nine and twelve months.
An intensive protocol using Curodont Repair Fluoride Plus had 6.5 times the odds of arresting decay compared with a standard Duraphat varnish, and nearly 20 times the odds of turning active lesions inactive.
A third product, MI varnish, was no better than Duraphat.
Why it matters
It is one of the clearer patient results in this field, and it still measures lesions rather than teeth saved.
1 source
An intensive varnish protocol on baby teeth
The full story
An intensive varnish protocol on baby teeth
A clinical study followed white spots on children's primary teeth for a year, checking them by eye and with a laser fluorescence meter at three, six, nine and twelve months. An intensive protocol using Curodont Repair Fluoride Plus had 6.5 times the odds of arresting decay compared with a standard Duraphat varnish, and nearly 20 times the odds of turning active lesions inactive.
Why it matters. It is one of the clearer patient results in this field, and it still measures lesions rather than teeth saved.
Nanosilver rinse and white spots in braces
Swipe up for the story ↑Scroll down for the story ↓
Fixed braces trap plaque where a brush cannot easily reach, and white spots are the common result.
A review of human trials found that after six months, 9.5% of teeth developed a white spot among people using a nanosilver mouthwash, against 24.4% for both fluoride and chlorhexidine rinses.
The upper right lateral incisor was the worst-affected tooth, at 38.1%.
Why it matters
Orthodontic patients are the group where prevention and damage run on the same two-year clock.
1 source
Nanosilver rinse and white spots in braces
The full story
Nanosilver rinse and white spots in braces
Fixed braces trap plaque where a brush cannot easily reach, and white spots are the common result. A review of human trials found that after six months, 9.5% of teeth developed a white spot among people using a nanosilver mouthwash, against 24.4% for both fluoride and chlorhexidine rinses.
Why it matters. Orthodontic patients are the group where prevention and damage run on the same two-year clock.
Acid drinks strip enamel with no bacteria involved
Swipe up for the story ↑Scroll down for the story ↓
Erosion is the chemical loss of tooth surface to acid that never passed through a microbe, and it is common: roughly 30% to 50% of children and 20% to 40% of adults.
The acid comes from fizzy drinks, fruit juice and energy drinks, or from stomach contents in reflux.
In one laboratory comparison, carbonated drinks roughened enamel the most, and brushing straight after an acid exposure made the loss worse.
Why it matters
It is a separate route to the same damage, and it does not respond to anything aimed at bacteria.
2 sources
Acid drinks strip enamel with no bacteria involved
The full story
Acid drinks strip enamel with no bacteria involved
Erosion is the chemical loss of tooth surface to acid that never passed through a microbe, and it is common: roughly 30% to 50% of children and 20% to 40% of adults.
Why it matters. It is a separate route to the same damage, and it does not respond to anything aimed at bacteria.
Stomach acid and kefir, tested on real molars
Swipe up for the story ↑Scroll down for the story ↓
Researchers took 80 baby second molars and 80 adult premolars and soaked them for 72 hours in gastric acid at pH 1.2 or in kefir at pH 4.5.
They then treated the samples with three commercial repair agents for 14 days, with artificial saliva alone as the control.
Reflux disease, which sends stomach contents back up the gullet, affects an estimated 10% to 30% of people worldwide.
Why it matters
It sets the size of the problem for anyone whose acid comes from inside rather than from a bottle.
1 source
Stomach acid and kefir, tested on real molars
The full story
Stomach acid and kefir, tested on real molars
Researchers took 80 baby second molars and 80 adult premolars and soaked them for 72 hours in gastric acid at pH 1.2 or in kefir at pH 4.5. They then treated the samples with three commercial repair agents for 14 days, with artificial saliva alone as the control.
Why it matters. It sets the size of the problem for anyone whose acid comes from inside rather than from a bottle.
Silver fluoride arrested nearly nine in ten molars
Swipe up for the story ↑Scroll down for the story ↓
A blinded trial randomised 165 children aged six to twelve by school.
One group had 38% silver diamine fluoride with potassium iodide painted on early decay in their first adult molars; the other had a 5% fluoride varnish.
After six months, 88.1% of the silver-treated teeth scored as sound, against 65.6% of the varnish ones.
Why it matters
Silver fluoride stains the treated spot black, which is why it is used most where a filling is not available.
How it works
A tooth cannot heal itself. What repairs it is the liquid around it.
How it works
Enamel has no living cells, so nothing inside the tooth rebuilds it; the minerals come from the saliva and paste outside.
How it works · step 1 of 6
Enamel is finished before the tooth appears, and holds no living cells
How it works · step 2 of 6
So nothing inside the tooth can rebuild it
How it works · step 3 of 6
But enamel is a crystal, and crystals dissolve and re-form
How it works · step 4 of 6
Acid in the mouth pulls calcium and phosphate out of it
How it works · step 5 of 6
Saliva, and whatever is put on the tooth, pushes them back in
How it works · step 6 of 6
So the repair is done by the surroundings, and stops when they stop
The twist
A part with no living cells in it still gets its mineral back.
The twist
The calcium and phosphate come from the saliva and the toothpaste outside, because nothing inside the tooth can supply them.
Seen the same day
the tooth does nothing; a liquid is painted on the surface, and it has to be painted on again about every six months
Seen the same day
skin can repair its own DNA and cannot keep up, so the protection that worked was a layer applied on top and renewed daily
Seen the same day
nothing is removed and the conditions inside are changed instead, and the same repeat-it problem shows up as 44.3% coming back for the operation
Seen the same day
the work is done on the outside of a tooth root and the change appears in a blood vessel, which is the same outside-in route
The catch
This only works while the enamel over the lesion has not broken.
The catch
Once it caves in and leaves a hole, no amount of mineral in the saliva puts it back, and the tooth needs a filling.
The whole
A dentist sees the tooth twice a year and reads a score.
The whole
What happened in between was thousands of small swings in one direction and then the other, and nobody watched any of them, including the person the tooth belongs to.
Who gains
Dental product firms with peptide and silver formulas
Silver diamine fluoride arrested 88.1% of early lesions against 65.6% for standard varnish, and a peptide beat fluoride on subsurface repair in all seven trials reviewed.
2 sources
Silver fluoride arrested nearly nine in ten molars
The full story
Silver fluoride arrested nearly nine in ten molars
A blinded trial randomised 165 children aged six to twelve by school. One group had 38% silver diamine fluoride with potassium iodide painted on early decay in their first adult molars; the other had a 5% fluoride varnish. After six months, 88.1% of the silver-treated teeth scored as sound, against 65.6% of the varnish ones.
Why it matters. Silver fluoride stains the treated spot black, which is why it is used most where a filling is not available.
Silver and sodium fluoride compared again
Swipe up for the story ↑Scroll down for the story ↓
An updated review pooled randomised trials comparing silver diamine fluoride with plain sodium fluoride in children under six.
Silver had higher odds of stopping a lesion, at 1.41, but no measurable advantage on the count of decayed, missing and filled surfaces.
Untreated decay in baby teeth affected about 532 million children in 2017, the tenth most common condition in the world.
Why it matters
Stopping a lesion that already exists and preventing the next one are two different jobs. Silver did better on the first and no better on the second.
1 source
Silver and sodium fluoride compared again
The full story
Silver and sodium fluoride compared again
An updated review pooled randomised trials comparing silver diamine fluoride with plain sodium fluoride in children under six. Silver had higher odds of stopping a lesion, at 1.41, but no measurable advantage on the count of decayed, missing and filled surfaces.
Why it matters. Stopping a lesion that already exists and preventing the next one are two different jobs. Silver did better on the first and no better on the second.
Varnish four times a year, and the number that follows
Swipe up for the story ↑Scroll down for the story ↓
A meta-analysis screened 2,315 records and analysed 13 randomised trials covering 4,784 participants. Fluoride varnish cut decay across the pooled group.
The largest effect was in younger children and in those with a dry mouth, where quarterly applications were associated with a 54% reduction and unwanted effects stayed below 5%.
Variation between the trials was high, which the authors put down to inconsistent application protocols.
Why it matters
The dose here is a schedule, not a quantity, and the benefit is counted per visit.
Good news
In younger children and in those with a dry mouth, fluoride varnish applied four times a year was associated with 54% less tooth decay, pooled across 13 randomised trials and 4,784 participants. It sits on the World Health Organization's list of medicines every country should keep in stock.
1 source
Varnish four times a year, and the number that follows
The full story
Varnish four times a year, and the number that follows
A meta-analysis screened 2,315 records and analysed 13 randomised trials covering 4,784 participants. Fluoride varnish cut decay across the pooled group. The largest effect was in younger children and in those with a dry mouth, where quarterly applications were associated with a 54% reduction and unwanted effects stayed below 5%.
Why it matters. The dose here is a schedule, not a quantity, and the benefit is counted per visit.
The health agency put varnish on its essential list
Swipe up for the story ↑Scroll down for the story ↓
The World Health Organization's guidance on mercury-free dental products reviewed ten systematic reviews of fluoride varnish.
It reports that twice a year beat once a year for preventing early childhood decay, with a mean caries increment 3.57 surfaces lower after a year in one study.
It found no treatment-related adverse events in the varnish trials, though few of them collected that information.
Why it matters
Being on that list is what makes a treatment something health ministries are expected to stock rather than something patients buy.
Who gains
Health ministries running varnish programmes
The Brazilian model puts the cost at about 33 reais a child a year, and the World Health Organization lists varnish as an essential medicine, which is what gets it into budgets.
2 sources
The health agency put varnish on its essential list
The full story
The health agency put varnish on its essential list
The World Health Organization's guidance on mercury-free dental products reviewed ten systematic reviews of fluoride varnish. It reports that twice a year beat once a year for preventing early childhood decay, with a mean caries increment 3.57 surfaces lower after a year in one study.
Why it matters. Being on that list is what makes a treatment something health ministries are expected to stock rather than something patients buy.
What varnish costs per cavity prevented
Swipe up for the story ↑Scroll down for the story ↓
An economic model followed Brazilian preschoolers over four years in six-month cycles.
Adding fluoride varnish to standard care prevented cavities in four children out of every 100, at an average cost of 33 Brazilian reais a child a year.
The full incremental cost came to R$6,929 per cavitated lesion prevented.
Why it matters
It is the number a health ministry actually decides on, and it is a different number from the trial result.
1 source
What varnish costs per cavity prevented
The full story
What varnish costs per cavity prevented
An economic model followed Brazilian preschoolers over four years in six-month cycles. Adding fluoride varnish to standard care prevented cavities in four children out of every 100, at an average cost of 33 Brazilian reais a child a year.
Why it matters. It is the number a health ministry actually decides on, and it is a different number from the trial result.
How common decay is by seventeen
Swipe up for the story ↑Scroll down for the story ↓
A review of 14 randomised trials across different countries and income levels pooled data from more than 13,000 children given fluoride varnish.
Its background section sets the scale: decay affects around 40% of seven-year-olds and about 85% of people by the age of 17.
The review cites reductions of roughly 37% in baby teeth and 47% in adult teeth.
Why it matters
Decay reaches almost everyone, so the practical argument is about getting varnish to children rather than about finding a new treatment.
Who pays
Children in places with no varnish programme
Decay reaches about 40% of seven-year-olds and 85% of people by 17, and untreated decay in baby teeth affected roughly 532 million children in 2017.
2 sources
How common decay is by seventeen
The full story
How common decay is by seventeen
A review of 14 randomised trials across different countries and income levels pooled data from more than 13,000 children given fluoride varnish. Its background section sets the scale: decay affects around 40% of seven-year-olds and about 85% of people by the age of 17.
Why it matters. Decay reaches almost everyone, so the practical argument is about getting varnish to children rather than about finding a new treatment.
The bacterium that turns sugar into acid
Swipe up for the story ↑Scroll down for the story ↓
Streptococcus mutans lives on tooth surfaces and ferments dietary sugar into lactic acid.
It also builds sticky sugar chains called glucans that glue it to enamel and hold the film together, and it can keep working at a low pH that silences its neighbours.
Sucrose matters most, because the glue is made from it.
Why it matters
The film is not a dirt layer to be scrubbed off but a community, and which members dominate it is decided partly by what arrives.
3 sources
The bacterium that turns sugar into acid
The full story
The bacterium that turns sugar into acid
Streptococcus mutans lives on tooth surfaces and ferments dietary sugar into lactic acid. It also builds sticky sugar chains called glucans that glue it to enamel and hold the film together, and it can keep working at a low pH that silences its neighbours.
Why it matters. The film is not a dirt layer to be scrubbed off but a community, and which members dominate it is decided partly by what arrives.
A sweetener that starved the film
Swipe up for the story ↑Scroll down for the story ↓
Researchers built a test platform to measure how cariogenic a sugar is, then compared allulose, a rare sugar used as a sweetener, against sucrose.
Habitual refined sugar reduces the variety of microbes in the mouth and favours the acid-makers.
The work was done in a laboratory model of the mouth, not in people.
Why it matters
Sugar substitutes are usually sold on calories; this is the other thing they change.
1 source
A sweetener that starved the film
The full story
A sweetener that starved the film
Researchers built a test platform to measure how cariogenic a sugar is, then compared allulose, a rare sugar used as a sweetener, against sucrose. Habitual refined sugar reduces the variety of microbes in the mouth and favours the acid-makers.
Why it matters. Sugar substitutes are usually sold on calories; this is the other thing they change.
Stevioside cut the sticky matrix
Swipe up for the story ↑Scroll down for the story ↓
Stevioside, the sweet compound from the stevia plant, was tested against Streptococcus mutans.
The bacterium builds its film using an enzyme, glucosyltransferase, that turns sucrose into glue, and it defends itself against acid with a tolerance response.
The extract interfered with biofilm formation and with those virulence traits.
Why it matters
If a sweetener cannot be turned into glue, the film has less to hold on with.
1 source
Stevioside cut the sticky matrix
The full story
Stevioside cut the sticky matrix
Stevioside, the sweet compound from the stevia plant, was tested against Streptococcus mutans. The bacterium builds its film using an enzyme, glucosyltransferase, that turns sucrose into glue, and it defends itself against acid with a tolerance response.
Why it matters. If a sweetener cannot be turned into glue, the film has less to hold on with.
A sugar from breast milk blocked the film
Swipe up for the story ↑Scroll down for the story ↓
Sialyllactose is one of the complex sugars in human milk that babies cannot digest.
Researchers grew Streptococcus mutans and mixed streptococcal species in the laboratory and tested those milk sugars and a fragment of them against biofilm formation.
The mouth holds more than 700 bacterial species and about 100 million to a billion cells in every millilitre of saliva.
Inside a film, bacteria are shielded from antibacterial agents and from immune cells.
Why it matters
It is one reason the film is hard to treat once formed, and why the work keeps returning to stopping it forming.
1 source
A sugar from breast milk blocked the film
The full story
A sugar from breast milk blocked the film
Sialyllactose is one of the complex sugars in human milk that babies cannot digest. Researchers grew Streptococcus mutans and mixed streptococcal species in the laboratory and tested those milk sugars and a fragment of them against biofilm formation.
Why it matters. It is one reason the film is hard to treat once formed, and why the work keeps returning to stopping it forming.
Mouth bacteria found further down
Swipe up for the story ↑Scroll down for the story ↓
Forensic scientists sampled 50 bodies aged from newborn to 94 and looked for Streptococcus mutans along the gut.
They found it in the mouth in 14 cases, 28%, in the gullet in three, in the stomach in one, in the small intestine in one and in the large intestine in four, 8%.
Oral bacteria are swallowed constantly with saliva and food.
Why it matters
Finding a bacterium somewhere does not show it does anything there. Most claims linking mouth microbes to the rest of the body still rest on where organisms were found.
Nobody knows yet
Whether mouth bacteria found further down the gut do anything there.
The forensic study reports Streptococcus mutans in the large intestine of 8% of 50 bodies. It measures presence, not effect.
1 source
Mouth bacteria found further down
The full story
Mouth bacteria found further down
Forensic scientists sampled 50 bodies aged from newborn to 94 and looked for Streptococcus mutans along the gut. They found it in the mouth in 14 cases, 28%, in the gullet in three, in the stomach in one, in the small intestine in one and in the large intestine in four, 8%.
Why it matters. Finding a bacterium somewhere does not show it does anything there. Most claims linking mouth microbes to the rest of the body still rest on where organisms were found.
What the mouth's 700 species live on
Swipe up for the story ↑Scroll down for the story ↓
The mouth's microbes divide the territory: some prefer tooth surfaces, some the tongue, some the pocket between tooth and gum.
Helpful species such as Veillonella, Actinomyces and Neisseria can crowd out the harmful ones, and some produce their own antibacterial proteins.
A systematic review of 22 studies, eight of them randomised trials, found diet is a major determinant of which species dominate.
More than 80% of Americans have had a cavity by their mid-thirties.
Why it matters
The tooth surface is the one part of the body where the resident population and the mineral balance are the same story.
2 sources
What the mouth's 700 species live on
The full story
What the mouth's 700 species live on
The mouth's microbes divide the territory: some prefer tooth surfaces, some the tongue, some the pocket between tooth and gum.
Why it matters. The tooth surface is the one part of the body where the resident population and the mineral balance are the same story.
Cleaning under the gum moved blood pressure
Swipe up for the story ↑Scroll down for the story ↓
A meta-analysis of randomised trials measured what happens elsewhere in the body after gum disease is treated.
Systolic blood pressure fell by an average of 4.64 millimetres of mercury and diastolic by 1.84.
C-reactive protein, a general marker of inflammation in the blood, fell by 0.58 milligrams per litre.
Why it matters
The change is made on a tooth surface and shows up in a blood vessel, which is what makes this a whole-body finding rather than a dental one.
How it works
the work is done on the outside of a tooth root and the change appears in a blood vessel, which is the same outside-in route
The idea, in story 11: A tooth cannot heal itself. What repairs it is the liquid around it. →1 source
Cleaning under the gum moved blood pressure
The full story
Cleaning under the gum moved blood pressure
A meta-analysis of randomised trials measured what happens elsewhere in the body after gum disease is treated. Systolic blood pressure fell by an average of 4.64 millimetres of mercury and diastolic by 1.84. C-reactive protein, a general marker of inflammation in the blood, fell by 0.58 milligrams per litre.
Why it matters. The change is made on a tooth surface and shows up in a blood vessel, which is what makes this a whole-body finding rather than a dental one.
Gum disease and heart attacks, in 146,001 people
Swipe up for the story ↑Scroll down for the story ↓
A meta-analysis pooled 17 studies covering 146,001 participants and 3,199 heart attacks. People with periodontitis had 84% higher odds of a heart attack, an odds ratio of 1.84.
Publication bias was detected; correcting for it brought the figure down to 1.26, still above one.
Bleeding when the gum is probed carried an odds ratio of 2.90 on its own.
Why it matters
The authors' own correction moves the number a long way, which is the honest size of what is known.
1 source
Gum disease and heart attacks, in 146,001 people
The full story
Gum disease and heart attacks, in 146,001 people
A meta-analysis pooled 17 studies covering 146,001 participants and 3,199 heart attacks. People with periodontitis had 84% higher odds of a heart attack, an odds ratio of 1.84.
Why it matters. The authors' own correction moves the number a long way, which is the honest size of what is known.
Heart failure risk 58% higher
Swipe up for the story ↑Scroll down for the story ↓
A separate review pooled long-running cohorts with follow-up between 5.4 and 13 years and mean ages from 43 to 65.
Gum disease was associated with a 58% higher risk of heart failure, a crude relative risk of 1.58.
Heart failure affects about 1% to 2% of people and more than 10% of those over 70.
The proposed route is bacteria and inflammatory signals entering the bloodstream from the gum.
Why it matters
It is the same suspected mechanism as the heart attack finding, measured on a different outcome.
1 source
Heart failure risk 58% higher
The full story
Heart failure risk 58% higher
A separate review pooled long-running cohorts with follow-up between 5.4 and 13 years and mean ages from 43 to 65. Gum disease was associated with a 58% higher risk of heart failure, a crude relative risk of 1.58.
Why it matters. It is the same suspected mechanism as the heart attack finding, measured on a different outcome.
Atrial fibrillation, and what recovery did to it
Swipe up for the story ↑Scroll down for the story ↓
A review of cohort studies found gum disease associated with irregular heart rhythm, with adjusted hazard ratios from 1.03 to 1.31. Severe disease carried the top of that range.
In people whose gum disease had recovered, the extra risk disappeared, with a hazard ratio of 1.00.
Gum disease affected about 951 million people in 2021 and accounted for 6.2 million years of healthy life lost.
Why it matters
The extra risk disappeared in people whose gum disease had cleared up. That is as close to a test as an observational study gets.
1 source
Atrial fibrillation, and what recovery did to it
The full story
Atrial fibrillation, and what recovery did to it
A review of cohort studies found gum disease associated with irregular heart rhythm, with adjusted hazard ratios from 1.03 to 1.31. Severe disease carried the top of that range.
Why it matters. The extra risk disappeared in people whose gum disease had cleared up. That is as close to a test as an observational study gets.
The heart body that says there is no link
Swipe up for the story ↑Scroll down for the story ↓
Meta-analyses of epidemiological work put the extra relative risk of a cardiovascular event at between 12% and 59% after adjusting for the usual risk factors.
A review by the American Heart Association, a US doctors' body, found no association between gum disease and cardiovascular events.
The authors state plainly that there is no conclusive evidence either way on whether gum disease is an independent risk factor.
More than 40% of adults over 30 in the United States have gum disease.
Why it matters
Two sets of experts read the same studies and came to opposite conclusions. Nobody has run the trial that would settle it.
Nobody knows yet
Whether gum disease causes heart disease or simply travels with it.
Meta-analyses put the extra relative risk at 12% to 59%, while a review by the American Heart Association found no association with cardiovascular events, and the authors say there is no conclusive evidence either way.
2 sources
The heart body that says there is no link
The full story
The heart body that says there is no link
Meta-analyses of epidemiological work put the extra relative risk of a cardiovascular event at between 12% and 59% after adjusting for the usual risk factors.
Why it matters. Two sets of experts read the same studies and came to opposite conclusions. Nobody has run the trial that would settle it.
A gum bacterium and the brain's barrier
Swipe up for the story ↑Scroll down for the story ↓
Porphyromonas gingivalis is the organism treated as the keystone of chronic gum disease, because it tips the whole microbial community out of balance.
Its outer coat contains lipopolysaccharide, which can enter the bloodstream, bind receptors on the cells lining brain blood vessels and make that barrier leakier.
Chronically raised inflammatory signals are proposed as the route to nerve damage in older people.
Why it matters
It is the same inflammation argument as the heart work, aimed at a different organ and standing on weaker evidence.
1 source
A gum bacterium and the brain's barrier
The full story
A gum bacterium and the brain's barrier
Porphyromonas gingivalis is the organism treated as the keystone of chronic gum disease, because it tips the whole microbial community out of balance.
Why it matters. It is the same inflammation argument as the heart work, aimed at a different organ and standing on weaker evidence.
Diabetes and gums pull each other
Swipe up for the story ↑Scroll down for the story ↓
A clinical review screened studies and kept 110 covering diabetes, gum disease and heart disease together.
High blood sugar produces advanced glycation end-products, which bind receptors on immune cells and raise inflammatory signalling.
People with poorly controlled diabetes have more and worse gum disease, and people with gum disease tend to have worse blood sugar control.
Treating the gums produced modest gains in blood sugar control.
Why it matters
High blood sugar makes gum disease worse, and gum disease makes blood sugar harder to control. Each one keeps feeding the other.
1 source
Diabetes and gums pull each other
The full story
Diabetes and gums pull each other
A clinical review screened studies and kept 110 covering diabetes, gum disease and heart disease together. High blood sugar produces advanced glycation end-products, which bind receptors on immune cells and raise inflammatory signalling.
Why it matters. High blood sugar makes gum disease worse, and gum disease makes blood sugar harder to control. Each one keeps feeding the other.
Ten years after antibiotics for appendicitis
Swipe up for the story ↑Scroll down for the story ↓
The APPAC trial in Finland randomised adults with appendicitis confirmed on a scan to surgery or to antibiotics, and has now reported ten-year results.
Of 257 patients given antibiotics, 253 were still being followed. Appendicitis came back, confirmed on tissue, in 37.8% of them, and 44.3% had had the appendix removed by ten years.
The treatment was three days of intravenous ertapenem then a week of tablets.
Why it matters
It is the longest randomised follow-up available on treating an organ rather than removing it, and the recurrence keeps accumulating.
How it works
nothing is removed and the conditions inside are changed instead, and the same repeat-it problem shows up as 44.3% coming back for the operation
The idea, in story 11: A tooth cannot heal itself. What repairs it is the liquid around it. →What's really going on
Where anyone has followed real patients a long way, the picture is harder: ten years after Finnish patients took antibiotics instead of having the appendix out, 44.3% had had it out anyway.
Who pays
The 44.3% of the Finnish antibiotic group
They had the drugs, the follow-up and then the operation. The cumulative rate was 39.1% at five years and 44.3% at ten, so it was still climbing.
Good news
Ten years after the Finnish appendicitis trial, 55.7% of the people given antibiotics had still never had the operation.
The full story
Ten years after antibiotics for appendicitis
The APPAC trial in Finland randomised adults with appendicitis confirmed on a scan to surgery or to antibiotics, and has now reported ten-year results. Of 257 patients given antibiotics, 253 were still being followed. Appendicitis came back, confirmed on tissue, in 37.8% of them, and 44.3% had had the appendix removed by ten years.
Why it matters. It is the longest randomised follow-up available on treating an organ rather than removing it, and the recurrence keeps accumulating.
What the first year looked like
Swipe up for the story ↑Scroll down for the story ↓
In APPAC's first year, 73% of patients with scan-confirmed uncomplicated appendicitis avoided an operation on antibiotics alone.
By five years the cumulative operation rate was 39.1%, with no rise in burst appendixes or serious complications among those who went on to surgery.
Complications overall were lower in the antibiotic group, 6.5% against 24.4% in the surgical group.
Why it matters
The trade is fewer complications now against a running chance of the operation later, and the trial reports both halves.
1 source
What the first year looked like
The full story
What the first year looked like
In APPAC's first year, 73% of patients with scan-confirmed uncomplicated appendicitis avoided an operation on antibiotics alone.
Why it matters. The trade is fewer complications now against a running chance of the operation later, and the trial reports both halves.
Three treatments ranked at once
Swipe up for the story ↑Scroll down for the story ↓
A network meta-analysis compared surgery, antibiotics and a newer keyhole technique that clears the appendix from the inside through a colonoscope.
On complications the endoscopic route came out best and surgery worst. On recurrence surgery came out best and antibiotics worst, with an odds ratio of 0.06 for surgery against antibiotics.
A separate review of ten studies in 1,372 children found no significant difference in recurrence between the endoscopic route and the comparison groups.
Why it matters
Each option wins on a different measure, so the choice depends on which failure a patient and a surgeon mind most.
2 sources
Three treatments ranked at once
The full story
Three treatments ranked at once
A network meta-analysis compared surgery, antibiotics and a newer keyhole technique that clears the appendix from the inside through a colonoscope. On complications the endoscopic route came out best and surgery worst. On recurrence surgery came out best and antibiotics worst, with an odds ratio of 0.06 for surgery against antibiotics.
Why it matters. Each option wins on a different measure, so the choice depends on which failure a patient and a surgeon mind most.
A stone in the appendix changes the odds
Swipe up for the story ↑Scroll down for the story ↓
A meta-analysis of six randomised trials covering 2,101 adults found 34% of antibiotic-treated patients needed an operation within a year, and a quarter of those turned out to have complicated appendicitis.
Patients with an appendicolith, a hardened lump blocking the appendix, did much worse: 49% needed surgery, with significantly higher complication rates.
Why it matters
It is the closest thing in this cluster to a rule for who the antibiotic route suits.
Nobody knows yet
Which appendicitis patients are in the 44.3% who come back.
The Finnish ten-year report gives the rate but not the profile. A separate meta-analysis found 49% of patients with a hardened lump blocking the appendix needed surgery, against 34% overall.
The full story
A stone in the appendix changes the odds
A meta-analysis of six randomised trials covering 2,101 adults found 34% of antibiotic-treated patients needed an operation within a year, and a quarter of those turned out to have complicated appendicitis.
Why it matters. It is the closest thing in this cluster to a rule for who the antibiotic route suits.
Sent home on tablets
Swipe up for the story ↑Scroll down for the story ↓
A single hospital reviewed every patient diagnosed with uncomplicated appendicitis between 2020 and 2022 who was discharged from the emergency department on oral antibiotics with no admission.
Of 99 patients, 76% were still free of surgery at one year, and 70% at a median follow-up of 34 months.
Four in five of the operations that did happen came within the first ten months.
Why it matters
The two cohorts disagree by a wide margin, and neither was randomised.
Who gains
Hospitals treating appendicitis without an operating theatre
One unit discharged 99 patients on tablets from the emergency department, and 70% had still avoided surgery at a median 34 months.
Nobody knows yet
How long a cohort's appendicitis results hold.
One hospital cohort reports 70% free of surgery at 34 months and another 95.7% success at a mean of 64 months. Neither was randomised and they disagree widely.
The full story
Sent home on tablets
A single hospital reviewed every patient diagnosed with uncomplicated appendicitis between 2020 and 2022 who was discharged from the emergency department on oral antibiotics with no admission. Of 99 patients, 76% were still free of surgery at one year, and 70% at a median follow-up of 34 months.
Why it matters. The two cohorts disagree by a wide margin, and neither was randomised.
The first new sunscreen filter in the United States in 25 years
Swipe up for the story ↑Scroll down for the story ↓
The US Food and Drug Administration has approved bemotrizinol, the first new active sunscreen ingredient cleared there in more than 25 years.
It was first proposed more than 20 years ago.
The United States regulates sunscreen as an over-the-counter drug, while the European Union treats it as a cosmetic, which is why filters available elsewhere have not been sold there.
Why it matters
What kept those filters out was the legal category sunscreen sits in, not a finding about the filters themselves. It decides which bottles reach which shelves.
Who gains
Sunscreen makers selling in the United States
Bemotrizinol is the first new active filter approved there in more than 25 years, opening a category that had been closed since the 1990s.
1 source
The first new sunscreen filter in the United States in 25 years
The full story
The first new sunscreen filter in the United States in 25 years
The US Food and Drug Administration has approved bemotrizinol, the first new active sunscreen ingredient cleared there in more than 25 years. It was first proposed more than 20 years ago. The United States regulates sunscreen as an over-the-counter drug, while the European Union treats it as a cosmetic, which is why filters available elsewhere have not been sold there.
Why it matters. What kept those filters out was the legal category sunscreen sits in, not a finding about the filters themselves. It decides which bottles reach which shelves.
Sixteen of twenty sunscreens missed their number
Swipe up for the story ↑Scroll down for the story ↓
The Australian consumer group CHOICE tested 20 widely sold sunscreens in 2025, from brands including Neutrogena, La Roche-Posay, Cancer Council and Banana Boat. All were labelled SPF 50 or above.
Sixteen came in below the claim, with readings in the forties, thirties and twenties.
SPF measures how much longer skin takes to burn with the product on than without it, tested on small patches of skin.
Why it matters
People pick a bottle by the number on the front.
Why it matters
That number comes from small patches of skin under careful application, and 16 of the 20 products did not reach it.
Who pays
People buying sunscreen above its real strength
Sixteen of 20 Australian products tested below their label, so the protection people paid for and planned around was not there.
Nobody knows yet
What a bottle's real SPF is.
Sixteen of 20 Australian products labelled SPF 50 or above tested lower, and the test itself is done on small patches of skin under controlled application.
Part of a signal
Proof that measures something else
Seen in 2 of the 12 beats
Also seen in Biotech.
The whole signal →1 source
Sixteen of twenty sunscreens missed their number
The full story
Sixteen of twenty sunscreens missed their number
The Australian consumer group CHOICE tested 20 widely sold sunscreens in 2025, from brands including Neutrogena, La Roche-Posay, Cancer Council and Banana Boat. All were labelled SPF 50 or above. Sixteen came in below the claim, with readings in the forties, thirties and twenties.
Why it matters. People pick a bottle by the number on the front. That number comes from small patches of skin under careful application, and 16 of the 20 products did not reach it.
The trial that showed sunscreen cutting a cancer
Swipe up for the story ↑Scroll down for the story ↓
The Nambour Skin Cancer Prevention Trial, run in a town in Queensland, Australia, randomly assigned 1,621 people to use sunscreen above SPF 15 every day or as they chose, over four and a half years.
Daily use was associated with 39% fewer squamous cell skin cancers by the end, and 38% fewer after eight years.
Why it matters
Almost everything else about sunscreen is measured on skin markers; this is one of the few results counted in tumours.
How it works
skin can repair its own DNA and cannot keep up, so the protection that worked was a layer applied on top and renewed daily
The idea, in story 11: A tooth cannot heal itself. What repairs it is the liquid around it. →Good news
In the Australian town of Nambour, 1,621 people were randomly assigned to use sunscreen every day or as they chose. After four and a half years, squamous cell skin cancer was 39% lower in the daily group.
1 source
The trial that showed sunscreen cutting a cancer
The full story
The trial that showed sunscreen cutting a cancer
The Nambour Skin Cancer Prevention Trial, run in a town in Queensland, Australia, randomly assigned 1,621 people to use sunscreen above SPF 15 every day or as they chose, over four and a half years. Daily use was associated with 39% fewer squamous cell skin cancers by the end, and 38% fewer after eight years.
Why it matters. Almost everything else about sunscreen is measured on skin markers; this is one of the few results counted in tumours.
What melanin does, and what nobody has tested
Swipe up for the story ↑Scroll down for the story ↓
In a study simulating sunlight across skin types, the melanin in the darkest skin gave about 60 times the protection against DNA damage in a deeper layer of skin compared with fair, European-origin skin.
The epidemiologists behind the Nambour trial say its result cannot simply be extended to people with darker skin, and that there is no trial evidence that sunscreen prevents cancer in them.
Why it matters
Advice given to everyone rests on evidence collected in one group, and the people running that trial are the ones saying so.
Who pays
People with darker skin given advice built on other people's data
The Nambour trial recruited in Queensland, and there is no equivalent evidence for skin types where melanin already gives about 60 times the protection against deep DNA damage.
Nobody knows yet
Whether sunscreen prevents skin cancer in people with darker skin.
The only large randomised trial was run in one Australian town, and its own investigators say the result cannot be extended to people of colour. No trial in that group exists.
2 sources
What melanin does, and what nobody has tested
The full story
What melanin does, and what nobody has tested
In a study simulating sunlight across skin types, the melanin in the darkest skin gave about 60 times the protection against DNA damage in a deeper layer of skin compared with fair, European-origin skin.
Why it matters. Advice given to everyone rests on evidence collected in one group, and the people running that trial are the ones saying so.
Sunscreen changed what the skin's genes did
Swipe up for the story ↑Scroll down for the story ↓
Thirty-two female volunteers across four skin types were given repeated moderate doses of ultraviolet light, with samples taken from untreated skin, unprotected exposed skin and skin covered with sunscreen first.
Repeated low doses that never redden the skin still switch on DNA repair, inflammation and stress responses.
Why it matters
It measures the damage that arrives below the level of a sunburn, which is the part nobody can feel.
1 source
Sunscreen changed what the skin's genes did
The full story
Sunscreen changed what the skin's genes did
Thirty-two female volunteers across four skin types were given repeated moderate doses of ultraviolet light, with samples taken from untreated skin, unprotected exposed skin and skin covered with sunscreen first.
Why it matters. It measures the damage that arrives below the level of a sunburn, which is the part nobody can feel.
Iron oxides block the light the filters miss
Swipe up for the story ↑Scroll down for the story ↓
Visible light makes up nearly half the solar spectrum, and the blue end of it drives pigmentation, oxidative stress and photoaging through a receptor on pigment cells.
Ordinary chemical UV filters do almost nothing beyond 400 nanometres.
In one trial in 20 people with darker skin types, a tinted product held pigmentation steady where unprotected skin darkened.
Why it matters
It matters most for people whose main complaint from the sun is patchy darkening rather than burning.
2 sources
Iron oxides block the light the filters miss
The full story
Iron oxides block the light the filters miss
Visible light makes up nearly half the solar spectrum, and the blue end of it drives pigmentation, oxidative stress and photoaging through a receptor on pigment cells.
Why it matters. It matters most for people whose main complaint from the sun is patchy darkening rather than burning.
Most of the added extras are untested
Swipe up for the story ↑Scroll down for the story ↓
Sunscreens increasingly carry non-filtering ingredients meant to add protection, from antioxidants to DNA repair enzymes.
A review counted them and found that fewer than 2% of the candidate ingredients have been clinically validated, and only 18 are approved for use in sunscreens.
It also notes that real-world protection falls short because people do not apply or reapply enough.
Why it matters
The claim on the front of the bottle is usually about the extras, and that is where the evidence is thinnest.
1 source
Most of the added extras are untested
The full story
Most of the added extras are untested
Sunscreens increasingly carry non-filtering ingredients meant to add protection, from antioxidants to DNA repair enzymes. A review counted them and found that fewer than 2% of the candidate ingredients have been clinically validated, and only 18 are approved for use in sunscreens.
Why it matters. The claim on the front of the bottle is usually about the extras, and that is where the evidence is thinnest.
Ultraviolet light rises with altitude
Swipe up for the story ↑Scroll down for the story ↓
Ultraviolet strength is not a fixed quantity. It rises by roughly 10% to 12% for every 1,000 metres of altitude, because there is less atmosphere above to absorb it.
Near the equator the ultraviolet index regularly passes 10 or 11, which the World Health Organization classes as very high, while temperate regions peak lower and seasonally.
Thinner ozone raises the shorter-wavelength UVB share.
Why it matters
The same bottle behaves differently in different places, which is part of why national rules on SPF differ.
1 source
Ultraviolet light rises with altitude
The full story
Ultraviolet light rises with altitude
Ultraviolet strength is not a fixed quantity. It rises by roughly 10% to 12% for every 1,000 metres of altitude, because there is less atmosphere above to absorb it.
Why it matters. The same bottle behaves differently in different places, which is part of why national rules on SPF differ.
Antibodies against blood you have never met
Swipe up for the story ↑Scroll down for the story ↓
Blood group A, B and O are sugars on the surface of red cells, and the ABO system is the only one where people make antibodies against the groups they lack without ever being exposed to them.
Babies start producing them at four to six months and reach a peak by about ten.
Around 20% of group A people of European descent belong to a weaker subgroup, most often A2, and some of them make antibodies against the stronger A1.
Why it matters
It is why blood typing is done twice, once for the cells and once for the serum, and why the two answers can disagree.
2 sources
Antibodies against blood you have never met
The full story
Antibodies against blood you have never met
Blood group A, B and O are sugars on the surface of red cells, and the ABO system is the only one where people make antibodies against the groups they lack without ever being exposed to them.
Why it matters. It is why blood typing is done twice, once for the cells and once for the serum, and why the two answers can disagree.
When the lab's two answers disagreed
Swipe up for the story ↑Scroll down for the story ↓
A hospital transfusion department collected every case over three years where the control tube in reverse typing clumped when it should not have.
Eleven patients turned out to carry anti-M antibodies. Nine of the eleven had produced a discrepancy between the two halves of the blood typing test.
Seven were transfused with blood from donors lacking the M antigen, all raised their haemoglobin and none had a reaction.
Why it matters
The mismatch between the two halves of the test is what tells the laboratory to look further. The patient is not treated for it; a different donor is found.
1 source
When the lab's two answers disagreed
The full story
When the lab's two answers disagreed
A hospital transfusion department collected every case over three years where the control tube in reverse typing clumped when it should not have. Eleven patients turned out to carry anti-M antibodies. Nine of the eleven had produced a discrepancy between the two halves of the blood typing test.
Why it matters. The mismatch between the two halves of the test is what tells the laboratory to look further. The patient is not treated for it; a different donor is found.
Learning to reject after nine bags of blood
Swipe up for the story ↑Scroll down for the story ↓
A five-year review looked at people with sickle cell disease who were transfused and had no previous antibodies. Of 805 patients, 325 qualified.
Fifty of them, 15.4%, developed a new antibody after a median of nine units of red cells, and 14% of those went on to make more.
The commonest were anti-C, anti-E and anti-K.
Why it matters
Each new antibody narrows the pool of blood that person can safely be given for the rest of their life.
Who pays
People with sickle cell disease on repeated transfusions
15.4% made a new red-cell antibody after a median of nine units, and each one narrows the blood they can safely be given afterwards.
The full story
Learning to reject after nine bags of blood
A five-year review looked at people with sickle cell disease who were transfused and had no previous antibodies. Of 805 patients, 325 qualified. Fifty of them, 15.4%, developed a new antibody after a median of nine units of red cells, and 14% of those went on to make more.
Why it matters. Each new antibody narrows the pool of blood that person can safely be given for the rest of their life.
Matching five Rh markers instead of one
Swipe up for the story ↑Scroll down for the story ↓
Routine crossmatching checks the RhD marker, the one that makes blood positive or negative. The Rh system also carries C, c, E and e, all capable of provoking antibodies.
Evidence in people needing repeated transfusion links extended matching across all five, and genetic typing of the underlying genes, to fewer new antibodies.
Mismatches can also complicate organ transplants, where graft survival suffers in ABO-incompatible cases.
Why it matters
It is prevention by bookkeeping: nothing is done to the patient, the donor unit is simply chosen more narrowly.
2 sources
Matching five Rh markers instead of one
The full story
Matching five Rh markers instead of one
Routine crossmatching checks the RhD marker, the one that makes blood positive or negative. The Rh system also carries C, c, E and e, all capable of provoking antibodies.
Why it matters. It is prevention by bookkeeping: nothing is done to the patient, the donor unit is simply chosen more narrowly.
A third of the dummy group got better
Swipe up for the story ↑Scroll down for the story ↓
An individual-patient meta-analysis pooled 1,703 people from nine trials of advanced drugs for ulcerative colitis, a long-term inflammation of the large bowel.
In the induction phase, 33% of people given placebo responded and 9% went into remission. In maintenance trials the figures were 28% and 14%.
Those are the rates a new drug has to beat, not zero.
Why it matters
It sets how large a real effect has to be before a trial can see it at all.
1 source
A third of the dummy group got better
The full story
A third of the dummy group got better
An individual-patient meta-analysis pooled 1,703 people from nine trials of advanced drugs for ulcerative colitis, a long-term inflammation of the large bowel. In the induction phase, 33% of people given placebo responded and 9% went into remission. In maintenance trials the figures were 28% and 14%.
Why it matters. It sets how large a real effect has to be before a trial can see it at all.
Placebo response fell as country income rose
Swipe up for the story ↑Scroll down for the story ↓
Researchers analysed 51 trials in psoriatic arthritis, covering 6,843 patients, and 43 in plaque psoriasis, covering 5,671.
They matched each trial's placebo response against the national income of the countries where it recruited.
Placebo response fell as income rose, by about 5.7 percentage points for every 10,000 international dollars in psoriatic arthritis.
Why it matters
Where a trial recruits changes the number it reports, before any drug is involved.
Nobody knows yet
Why placebo response falls as a country's income rises.
The association held across 51 psoriatic arthritis trials and 43 psoriasis trials, and the analysis reports the pattern without establishing what produces it.
1 source
Placebo response fell as country income rose
The full story
Placebo response fell as country income rose
Researchers analysed 51 trials in psoriatic arthritis, covering 6,843 patients, and 43 in plaque psoriasis, covering 5,671. They matched each trial's placebo response against the national income of the countries where it recruited. Placebo response fell as income rose, by about 5.7 percentage points for every 10,000 international dollars in psoriatic arthritis.
Why it matters. Where a trial recruits changes the number it reports, before any drug is involved.
Active dummies barely changed the answer
Swipe up for the story ↑Scroll down for the story ↓
An active placebo is a dummy designed to produce the same side effects as the real drug, so participants cannot guess which arm they are in.
A meta-epidemiological study gathered 67 reviews, 123 meta-analyses and 1,698 trials to see whether ordinary placebos inflate drug effects.
On average they did, by about 2%, which the authors call slight. Variation between meta-analyses was considerable.
Why it matters
A long-standing worry about trial design turns out, on the largest look at it so far, to be small on average.
1 source
Active dummies barely changed the answer
The full story
Active dummies barely changed the answer
An active placebo is a dummy designed to produce the same side effects as the real drug, so participants cannot guess which arm they are in. A meta-epidemiological study gathered 67 reviews, 123 meta-analyses and 1,698 trials to see whether ordinary placebos inflate drug effects. On average they did, by about 2%, which the authors call slight. Variation between meta-analyses was considerable.
Why it matters. A long-standing worry about trial design turns out, on the largest look at it so far, to be small on average.
The sham group's gain did not vanish when they were told
Swipe up for the story ↑Scroll down for the story ↓
REDUCE LAP-HF II randomised heart failure patients to a shunt implanted in the heart or to a sham procedure, and unblinded everyone after two years.
Among 421 participants, the sham group's quality-of-life score had improved by 9.3 points at two years, and fell by only 1.7 points in the year after they learned which arm they were in.
The estimated placebo component was two points or less.
Why it matters
Patient-reported scores are often dismissed as soft; this design tested that directly and found the softness small.
1 source
The sham group's gain did not vanish when they were told
The full story
The sham group's gain did not vanish when they were told
REDUCE LAP-HF II randomised heart failure patients to a shunt implanted in the heart or to a sham procedure, and unblinded everyone after two years. Among 421 participants, the sham group's quality-of-life score had improved by 9.3 points at two years, and fell by only 1.7 points in the year after they learned which arm they were in.
Why it matters. Patient-reported scores are often dismissed as soft; this design tested that directly and found the softness small.
Melatonin did not prevent delirium
Swipe up for the story ↑Scroll down for the story ↓
A double-blind trial gave hospitalised patients aged 65 and over nightly melatonin at 5 or 8 milligrams, or a placebo, for up to five days.
It was stopped early for futility with 109 patients analysed.
Delirium appeared in 3.64% of the melatonin group and 1.85% of the placebo group, a difference that was not significant, and sleep duration, 28-day deaths and readmissions did not differ either.
The authors say the low event rate left the trial underpowered.
Why it matters
A negative trial stopped early answers less than it looks, and the authors say so themselves.
1 source
Melatonin did not prevent delirium
The full story
Melatonin did not prevent delirium
A double-blind trial gave hospitalised patients aged 65 and over nightly melatonin at 5 or 8 milligrams, or a placebo, for up to five days. It was stopped early for futility with 109 patients analysed. Delirium appeared in 3.64% of the melatonin group and 1.85% of the placebo group, a difference that was not significant, and sleep duration, 28-day deaths and readmissions did not differ either.
Why it matters. A negative trial stopped early answers less than it looks, and the authors say so themselves.
A stroke drug beat placebo by five points
Swipe up for the story ↑Scroll down for the story ↓
TASTE-2 randomised 1,362 people having a stroke caused by a blocked large vessel, all of them due for a procedure to pull the clot out.
They received edaravone dexborneol or placebo before the procedure and twice daily for 10 to 14 days.
At 90 days, 55.0% of the treated group were functionally independent against 49.6% on placebo, a difference of 5.4 percentage points with a p value of 0.05.
Why it matters
It is a result sitting exactly on the conventional line, which is the kind that gets argued about for years.
1 source
A stroke drug beat placebo by five points
The full story
A stroke drug beat placebo by five points
TASTE-2 randomised 1,362 people having a stroke caused by a blocked large vessel, all of them due for a procedure to pull the clot out. They received edaravone dexborneol or placebo before the procedure and twice daily for 10 to 14 days. At 90 days, 55.0% of the treated group were functionally independent against 49.6% on placebo, a difference of 5.4 percentage points with a p value of 0.05.
Why it matters. It is a result sitting exactly on the conventional line, which is the kind that gets argued about for years.
Two more trials, two different answers
Swipe up for the story ↑Scroll down for the story ↓
OLINGUITO is a phase 3 programme of two randomised studies in axial spondyloarthritis, a form of spinal arthritis. Filgotinib beat placebo in both.
In the first, 39.5% of 258 patients reached the main response target against 20.9% on placebo; in the second, 34.5% against 17.8%.
In HypoBar I, a crossover trial in people with low blood sugar after weight-loss surgery, neither acarbose nor canagliflozin reduced time spent below the threshold compared with placebo.
Why it matters
Both trials used the same design and the same kind of control, and the control is what makes the two answers comparable.
2 sources
Two more trials, two different answers
The full story
Two more trials, two different answers
OLINGUITO is a phase 3 programme of two randomised studies in axial spondyloarthritis, a form of spinal arthritis. Filgotinib beat placebo in both. In the first, 39.5% of 258 patients reached the main response target against 20.9% on placebo; in the second, 34.5% against 17.8%.
Why it matters. Both trials used the same design and the same kind of control, and the control is what makes the two answers comparable.
Doctors using a dummy that announces itself
Swipe up for the story ↑Scroll down for the story ↓
An open-label placebo is a dummy pill given to someone who has been told it is a dummy.
A systematic review assessed 15 randomised trials, nine with some concerns and six at low risk of bias.
It reports that 77% of family doctors in Britain use open-label placebos, on the grounds that they cost little and carry no drug side effects.
Placebo responses engage brain networks handling pain, emotion and reward.
Why it matters
It removes the deception that made placebos an ethical problem, and leaves the question of what is actually happening.
The full story
Doctors using a dummy that announces itself
An open-label placebo is a dummy pill given to someone who has been told it is a dummy. A systematic review assessed 15 randomised trials, nine with some concerns and six at low risk of bias. It reports that 77% of family doctors in Britain use open-label placebos, on the grounds that they cost little and carry no drug side effects.
Why it matters. It removes the deception that made placebos an ethical problem, and leaves the question of what is actually happening.
That's the whole Mind & body day.
54 stories, 66 sources.